Active Biotech Overview

  • Year Founded
  • 1996

Year Founded

  • Status
  • Public

  • Employees
  • 5

Employees

  • Stock Symbol
  • ACTI

Stock Symbol

  • Share Price
  • $0.35
  • (As of Friday Closing)

Active Biotech General Information

Description

Active Biotech AB focuses on the research and development of pharmaceuticals products within medical areas including neurodegenerative diseases, autoimmune/inflammatory disease and various forms of cancer. Its project portfolio contains both small molecules that are orally active immunomodulatory agents and antibody based immunotherapy. Its project portfolio includes both small orally active immunomodulatory molecules and antibody-based immunotherapy. Its pipeline products are: Tasquinimod, Laquinimod, and Naptumomab.

Contact Information

Formerly Known As
Active I Malmo
Ownership Status
Publicly Held
Financing Status
Corporation
Corporate Office
  • Scheelevägen 22
  • 223 63 Lund
  • Sweden
+46 046-19
Primary Industry
Drug Discovery
Stock Exchange
STO
Vertical(s)
Corporate Office
  • Scheelevägen 22
  • 223 63 Lund
  • Sweden
+46 046-19

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Active Biotech Stock Performance

As of 13-Nov-2026, Active Biotech’s stock price is $0.35. Its current market cap is $9.3M with 26.4M shares.

(As of Friday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$0.35 $0.35 $0.31 - $1.02 $9.3M 26.4M 56.5K -$0.21

Active Biotech Financials Summary

As of 30-Sep-2026, Active Biotech has a trailing 12-month revenue of null.

In Thousands,
USD
TTM 30-Sep-2026 FY 2025 31-Dec-2025 FY 2024 31-Dec-2024 FY 2023 31-Dec-2023
EV 6,025 12,210 9,970 15,963
Revenue 0 0 0 0
EBITDA (3,725) (3,669) (3,615) (4,156)
Net Income (3,821) (3,799) (3,725) (4,309)
Total Assets 4,112 7,630 3,914 4,407
Total Debt 0 189 289 455
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Active Biotech Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Active Biotech‘s full profile, request access.

Request a free trial

Active Biotech Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Active Biotech AB focuses on the research and development of pharmaceuticals products within medical areas including neu
Drug Discovery
Lund, Sweden
5 As of 2026

Loos, France
 

Abingdon, United Kingdom
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Active Biotech Competitors (40)

One of Active Biotech’s 40 competitors is Genfit, a Formerly VC-backed company based in Loos, France.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Genfit Formerly VC-backed Loos, France
Immunocore Holdings Formerly VC-backed Abingdon, United Kingdom
Idorsia Pharmaceuticals Corporation Allschwil, Switzerland
Sorrento Therapeutics Formerly VC-backed San Diego, CA
Aprea Therapeutics Formerly VC-backed Doylestown, PA
You’re viewing 5 of 40 competitors. Get the full list »

Active Biotech Patents

Active Biotech Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2025006886-A1 Quinoline carboxamides for use in the treatment of men Inactive 28-Jun-2023
AU-2024306742-A1 Quinoline carboxamides for use in the treatment of mpn Pending 28-Jun-2023
EP-4734995-A1 Quinoline carboxamides for use in the treatment of mpn Pending 28-Jun-2023
WO-2025006886-A9 Quinoline carboxamides for use in the treatment of mpn Inactive 28-Jun-2023
AU-2022303084-A1 A pharmaceutical product containing tasquinimod and a method for assessing the purity of said product Pending 02-Jul-2021 A61K31/4704
To view Active Biotech’s complete patent history, request access »

Active Biotech Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Active Biotech Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Active Biotech‘s full profile, request access.

Request a free trial

Active Biotech ESG

Risk Overview

Risk Rating

Updated June, 30, 2023

28.12 | Med Risk

Risk Scale

A lower score indicates better sustainability

Negl

0-10

Low

10-20

Med

20-30

High

30-40

Severe

40+

Exposure

Exposure refers to the extent to which a company is exposed to different material ESG issues

Management

Management is related to actions taken to manage ESG issues

Peers Analysis

Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.

Global

Covered Companies

of 14,766

Rank

Percentile

Pharmaceuticals

Industry

of 891

Rank

Percentile

Biotechnology

Subindustry

of 394

Rank

Percentile

To view Active Biotech’s complete esg history, request access »

Active Biotech FAQs

  • When was Active Biotech founded?

    Active Biotech was founded in 1996.

  • Where is Active Biotech headquartered?

    Active Biotech is headquartered in Lund, Sweden.

  • What is the size of Active Biotech?

    Active Biotech has 5 total employees.

  • What industry is Active Biotech in?

    Active Biotech’s primary industry is Drug Discovery.

  • Is Active Biotech a private or public company?

    Active Biotech is a Public company.

  • What is Active Biotech’s stock symbol?

    The ticker symbol for Active Biotech is ACTI.

  • What is the current stock price of Active Biotech?

    As of 13-Nov-2026 the stock price of Active Biotech is $0.35.

  • What is the current market cap of Active Biotech?

    The current market capitalization of Active Biotech is $9.3M.

  • Who are Active Biotech’s competitors?

    Genfit, Immunocore Holdings, Idorsia Pharmaceuticals, Sorrento Therapeutics, and Aprea Therapeutics are some of the 40 competitors of Active Biotech.

  • What is Active Biotech’s annual earnings per share (EPS)?

    Active Biotech’s EPS for 12 months was -$0.21.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process